154 related articles for article (PubMed ID: 25553301)
1. Two cases of acute lymphoblastic leukemia with an e1a3 BCR-ABL1 fusion transcript.
Shin SY; Cho JH; Kim HJ; Jang JH; Lee ST; Kim SH
Ann Lab Med; 2015 Jan; 35(1):159-61. PubMed ID: 25553301
[No Abstract] [Full Text] [Related]
2. The e1a3 BCR-ABL1 fusion transcript in philadelphia chromosome-positive acute lymphoblastic leukemia.
Langabeer SE
Ann Lab Med; 2015 Sep; 35(5):540-1. PubMed ID: 26206693
[No Abstract] [Full Text] [Related]
3. Expression profiling of adult acute lymphoblastic leukemia identifies a BCR-ABL1-like subgroup characterized by high non-response and relapse rates.
Boer JM; Koenders JE; van der Holt B; Exalto C; Sanders MA; Cornelissen JJ; Valk PJ; den Boer ML; Rijneveld AW
Haematologica; 2015 Jul; 100(7):e261-4. PubMed ID: 25769542
[No Abstract] [Full Text] [Related]
4. Advances in therapy for Philadelphia-positive acute lymphoblastic leukaemia of childhood and adolescence.
Bleckmann K; Schrappe M
Br J Haematol; 2016 Mar; 172(6):855-69. PubMed ID: 26773444
[TBL] [Abstract][Full Text] [Related]
5. Clinical impact of low-burden BCR-ABL1 mutations detectable by amplicon deep sequencing in Philadelphia-positive acute lymphoblastic leukemia patients.
Soverini S; De Benedittis C; Papayannidis C; Polakova KM; Venturi C; Russo D; Bresciani P; Iurlo A; Mancini M; Vitale A; Chiaretti S; Foà R; Abruzzese E; Sorà F; Kohlmann A; Haferlach T; Baccarani M; Cavo M; Martinelli G
Leukemia; 2016 Jul; 30(7):1615-9. PubMed ID: 26867670
[No Abstract] [Full Text] [Related]
6. The e1a3
Chen Z
Hematology; 2023 Dec; 28(1):2186040. PubMed ID: 36912524
[No Abstract] [Full Text] [Related]
7. Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia with e1a3 BCR-ABL1 transcript in a Nigerian with sickle cell anemia: a case report.
Ahmed IO; Ochogwu LO; Owojuyigbe TO; Akinola NO; Durosinmi MA
J Med Case Rep; 2021 Oct; 15(1):504. PubMed ID: 34625105
[TBL] [Abstract][Full Text] [Related]
8. BCR/ABL rearrangement with b3a3 fusion transcript in a case of childhood acute lymphoblastic leukemia.
Kim J; Park TS; Lyu CJ; Song J; Lee KA; Kim SJ; Lee HJ; Choi JR
Cancer Genet Cytogenet; 2009 Mar; 189(2):132-7. PubMed ID: 19215796
[TBL] [Abstract][Full Text] [Related]
9. Increasing the BCR-ABL expression levels and/or the occurrence of ABL point mutations does not always predict resistance to Imatinib Mesylate in BCR-ABL positive acute lymphoblastic leukemia.
Grammatico S; Elia L; Peluso AL; Pedace L; Matarazzo M; Vitale A; Rago A; Pane F; Foà R; Cimino G
Leuk Res; 2009 Jul; 33(7):e73-4. PubMed ID: 19108887
[No Abstract] [Full Text] [Related]
10. BCR/ABL1 Kinase Domain Mutation Monitoring: Could Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Benefit As Well?
Andolina JR
Acta Haematol; 2015; 134(2):69-70. PubMed ID: 25895547
[No Abstract] [Full Text] [Related]
11. Adult acute lymphoblastic leukemia with a rare b3a3 type BCR/ABL1 fusion transcript.
Kurita D; Hatta Y; Hojo A; Kura Y; Sawada U; Kanda Y; Takei M
Cancer Genet; 2016 Apr; 209(4):161-5. PubMed ID: 26854094
[TBL] [Abstract][Full Text] [Related]
12. Drug resistance and BCR-ABL kinase domain mutations in Philadelphia chromosome-positive acute lymphoblastic leukemia from the imatinib to the second-generation tyrosine kinase inhibitor era: The main changes are in the type of mutations, but not in the frequency of mutation involvement.
Soverini S; De Benedittis C; Papayannidis C; Paolini S; Venturi C; Iacobucci I; Luppi M; Bresciani P; Salvucci M; Russo D; Sica S; Orlandi E; Intermesoli T; Gozzini A; Bonifacio M; Rigolin GM; Pane F; Baccarani M; Cavo M; Martinelli G
Cancer; 2014 Apr; 120(7):1002-9. PubMed ID: 24382642
[TBL] [Abstract][Full Text] [Related]
13. [Adult acute lymphoblastic leukemia with atypical BCR-ABL transcript e1a3: a case report and literature review].
Chen Y; Wang HW; Chen XH; Xu ZF; Qin YH; Ren FG; Li GX; Liang D; Liu DD
Zhonghua Xue Ye Xue Za Zhi; 2013 Nov; 34(11):965-6. PubMed ID: 24294854
[No Abstract] [Full Text] [Related]
14. Prevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemia.
Pfeifer H; Lange T; Wystub S; Wassmann B; Maier J; Binckebanck A; Giagounidis A; Stelljes M; Schmalzing M; Dührsen U; Wunderle L; Serve H; Brück P; Schmidt A; Hoelzer D; Ottmann OG
Leukemia; 2012 Jul; 26(7):1475-81. PubMed ID: 22230800
[TBL] [Abstract][Full Text] [Related]
15. BCR-ABL1 positive lymphoblastic lymphoma - should it be treated like a B-lymphoblastic leukemia with
Takahashi T; Ichikawa S; Ichinohasama R; Harigae H
Leuk Lymphoma; 2020 May; 61(5):1265-1267. PubMed ID: 31876209
[No Abstract] [Full Text] [Related]
16. Atypical BCR-ABL mRNA transcripts in adult acute lymphoblastic leukemia.
Burmeister T; Schwartz S; Taubald A; Jost E; Lipp T; Schneller F; Diedrich H; Thomssen H; Mey UJ; Eucker J; Rieder H; Gökbuget N; Hoelzer D; Thiel E
Haematologica; 2007 Dec; 92(12):1699-702. PubMed ID: 18055996
[TBL] [Abstract][Full Text] [Related]
17. A farnesyltransferase inhibitor increases survival of mice with very advanced stage acute lymphoblastic leukemia/lymphoma caused by P190 Bcr/Abl.
Mishra S; Zhang B; Groffen J; Heisterkamp N
Leukemia; 2004 Jan; 18(1):23-8. PubMed ID: 14603339
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in pregnancy.
Mainor CB; Duffy AP; Atkins KL; Kimball AS; Baer MR
J Oncol Pharm Pract; 2016 Apr; 22(2):374-7. PubMed ID: 25616656
[TBL] [Abstract][Full Text] [Related]
19. ABL1 gene deletion without BCR/ABL1 rearrangement in a young adolescent with precursor B-cell acute lymphoblastic leukemia: clinical study and literature review.
Kim MJ; Yoon HS; Lim G; Kim SY; Lee HJ; Suh JT; Lee J; Lee WI; Park TS
Cancer Genet Cytogenet; 2010 Jan; 196(2):184-8. PubMed ID: 20082857
[TBL] [Abstract][Full Text] [Related]
20. Incidence and clinical importance of BCR-ABL1 mutations in Iranian patients with chronic myeloid leukemia on imatinib.
Rostami G; Hamid M; Yaran M; Khani M; Karimipoor M
J Hum Genet; 2015 May; 60(5):253-8. PubMed ID: 25740611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]